Effect of Trichostatin A on Anti HepG2 Liver Carcinoma Cells: Inhibition of HDAC Activity and Activation of Wnt/β-Catenin Signaling |
Shi, Qing-Qiang
(Laboratory of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University)
Zuo, Guo-Wei (Laboratory of Clinical Diagnostics, Chongqing Medical University) Feng, Zi-Qiang (Laboratory of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University) Zhao, Lv-Cui (Laboratory of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University) Luo, Lian (Laboratory of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University) You, Zhi-Mei (Laboratory of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University) Li, Dang-Yang (Laboratory of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University) Xia, Jing (Laboratory of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University) Li, Jing (Laboratory of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University) Chen, Di-Long (Laboratory of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University) |
1 | Bai L, Merchant JL (2007). A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion. FEBS Letters, 581, 5904-10. DOI ScienceOn |
2 | Barbetti V, Gozzini A, Cheloni G, et al (2013). Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells. Epigenetics, 8, 210-9. DOI |
3 | Chen W-Q, Xu B, Mao J-W, et al (2014). Inhibitory effects of -pinene on hepatoma carcinoma cell proliferation. Asian Pac J Cancer Prev, 15, 3293-7. 과학기술학회마을 DOI ScienceOn |
4 | Cui J, Zhou X, Liu Y, et al (2001). Mutation and overexpression of the -catenin gene may play an important role in primary hepatocellular carcinoma among Chinese people. J Cancer Res Clin Oncol, 127, 577-81. DOI ScienceOn |
5 | Dahmani R, Just PA, Perret C (2011). The Wnt/-catenin pathway as a therapeutic target in human hepatocellular carcinoma. Clin Res Hepatol Gastroenterol, 35, 709-13. DOI |
6 | Debeb BG, Lacerda L, Xu W, et al (2012). Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/-catenin signaling. Stem Cells, 30, 2366-77. DOI |
7 | Herold C, Ganslmayer M, Ocker M, et al (2002). The histonedeacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. J Hepatol, 36, 233-40. |
8 | Feng D, Wu J, Tian Y, et al (2013). Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model. PLoS One, 8, 80657-68. DOI |
9 | Fujisawa K, Maesawa C, Sato R, et al (2005). Epigenetic status and aberrant expression of the maspin gene in human hepatobiliary tract carcinomas. Lab Invest, 85, 214-24. DOI ScienceOn |
10 | Haghshenas MR, Arabi M, Mousavi T (2014). Hepatitis B genotypes in iran. Mater Sociomed, 26, 129-33. DOI ScienceOn |
11 | Iguchi H, Urashima Y, Inagaki Y, et al (2007). SOX6 suppresses cyclin D1 promoter activity by interacting with -catenin and histone deacetylase 1, and its down-regulation induces pancreatic -cell proliferation. J Biol Chem, 282, 19052-61. DOI ScienceOn |
12 | Ji Z, Wang T, Shao Z, et al (2014). A population-based study examining hepatitis B virus infection and immunization rates in Northwest China. PLoS One, 9, 97474-84. DOI ScienceOn |
13 | Ker CG, Chen JS, Kuo KK, et al (2011). Liver surgery for hepatocellular carcinoma: laparoscopic versus open approach. Int J Hepatol, 2011, 596792. |
14 | Lazarova DL, Bordonaro M, Carbone R, et al (2004). Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate. Int J Cancer, 110, 523-31. DOI ScienceOn |
15 | Lee JE, Bae SH, Choi JY, et al (2014). Epirubicin, cisplatin, 5-FU combination chemotherapy in sorafenib-refractory metastatic hepatocellular carcinoma. World J Gastroenterol, 20, 235-41. DOI ScienceOn |
16 | Miyoshi H, Deguchi A, Nakau M, et al (2009). Hepatocellular carcinoma development induced by conditional -catenin activation in Lkb1+/- mice. Cancer Sci, 100, 2046-53. DOI ScienceOn |
17 | Mosimann C, Hausmann G, Basler K (2009). Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat Rev Mol Cell Biol, 10, 276-86. DOI ScienceOn |
18 | Li J-P, Cao N-X, Jiang R-T, et al (2014). Knockdown of GCF2/LRRFIP1 by RNAi causes cell growth inhibition and increased apoptosis in human hepatoma HepG2 cells. Asian Pac J Cancer Prev, 15, 2753-8. 과학기술학회마을 DOI ScienceOn |
19 | Marks P, Rifkind RA, Richon VM, et al (2001). Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer, 1, 194-202. DOI ScienceOn |
20 | Miyahara K, Nouso K, Yamamoto K (2014). Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age. World J Gastroenterol, 20, 4151-9. DOI ScienceOn |
21 | Myzak MC, Karplus PA, Chung FL, et al (2004). A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res, 64, 5767-74. DOI ScienceOn |
22 | Osaki A, Suda T, Kamimura K, et al (2013). A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma. Cancer Med, 2, 86-98. DOI |
23 | Page AJ, Cosgrove DC, Philosophe B, et al (2014). Hepatocellular carcinoma: diagnosis, management, and prognosis. Surg Oncol Clin N Am, 23, 289-311. DOI ScienceOn |
24 | Pathil A, Armeanu S, Venturelli S, et al (2006). HDAC inhibitor treatment of hepatoma cells induces both TRAILindependent apoptosis and restoration of sensitivity to TRAIL. Hepatology, 43, 425-34. DOI ScienceOn |
25 | Quint K, Agaimy A, Di Fazio P, et al (2011). Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC. Virchows Arch, 459, 129-39. DOI ScienceOn |
26 | Tanase A-M, Dumitrascu T, Dima S, et al (2014). Influence of hepatitis viruses on clinico-pathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma. Hepatobiliary Pancreatic Dis Int, 13, 162-72. DOI |
27 | Thompson MD, Monga SP (2007). WNT/-catenin signaling in liver health and disease. Hepatology, 45, 1298-305. DOI ScienceOn |
28 | Scaggiante B, Kazemi M, Pozzato G, et al (2014). Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials. World J Gastroenterol, 20, 1268-88. DOI ScienceOn |
29 | Shao N, Zou J, Li J, et al (2012). Hyper-activation of WNT/-catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemia. Leuk Lymphoma, 53, 1769-78. DOI ScienceOn |
30 | Song W-F, Wang L, Huang W-Y, et al (2013). MiR-21 upregulation induced by promoter zone histone acetylation is associated with chemoresistance to gemcitabine and enhanced malignancy of pancreatic cancer cells. Asian Pac J Cancer Prev, 14, 7529-36. 과학기술학회마을 DOI ScienceOn |
31 | Tsai WL, Lai KH, Liang HL, et al (2014). Hepatic arterial infusion chemotherapy for patients with huge unresectable hepatocellular carcinoma. PLoS One, 9, 92784. DOI ScienceOn |
32 | Venturelli S, Armeanu S, Pathil A, et al (2007). Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma. Cancer, 109, 2132-41. DOI ScienceOn |
33 | Wiltse J (2005). Mode of Action: Inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin-developmental effects of valproic acid. Crit Rev Toxicol, 35, 727-38. DOI ScienceOn |
34 | Woo HJ, Lee SJ, Choi BT, et al (2007). Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells. Exp Mol Pathol, 82, 77-84. DOI ScienceOn |
35 | Ying Y, Tao Q (2009). Epigenetic disruption of the WNT/-catenin signaling pathway in human cancers. Epigenetics, 4, 307-12. DOI |
36 | Zhang Q-C, Jiang S-J, Zhang S, et al (2012). Histone deacetylase inhibitor trichostatin a enhances antitumor effects of docetaxel or erlotinib in A549 cell line. Asian Pac J Cancer Prev, 13, 3471-6. 과학기술학회마을 DOI ScienceOn |
37 | Xu L-B (2010). Staging systems for predicting survival of patients with hepatocellular carcinoma after surgery. World Journal of Gastroenterology, 16, 5257. DOI |
38 | Yang XJ, Seto E (2007). HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene, 26, 5310-8. DOI ScienceOn |